---
created: 2025-04-13
updated: 2025-04-13T10:52
id: N<nQ%ECZk+
specialty: ortho
specialty_id: 24
tags:
  - source/ak-original-decks::step-1::zanki-pharmacology
  - "source/ak-step1-v11:": 
  - theme/firstaid::05-pharmacology::02-autonomic-drugs::15-phosphodiesterase-inhibitors
  - "source/ak-step1-v11:": 
  - theme/firstaid::05-pharmacology::02-autonomic-drugs::15-phosphodiesterase-inhibitors::pgi-2-analogs
  - "source/ak-step1-v11:": 
  - source/ome-banner::basic-science::10-musculoskeletal
  - "source/ak-step1-v11:": 
  - theme/physeo::09-pharm::09-musculoskeletal::04-nsaids
  - "source/ak-step1-v11:": 
  - theme/pixorize::03-pharm::12-msk::nsaids
  - "source/ak-step1-v11:": 
  - theme/pixorize::03-pharm::19-respiratory::prostaglandin-analogs-(epoprostenol,-iloprost)
  - "source/ak-step1-v11:": 
  - theme/sketchypharm::03-blood-&-inflammation::03-anti-inflammatory::01-nsaids
  - source/ak-step1-v11::^other::^expn
  - source/ak-step1-v11::^other::^highyield::1-highyield
  - source/ak-step1-v11::^systems::musculoskeletal::pharmacology"
type: flashcard
---

# Question
Prostacyclin analogs (epoprostenol/iloprost) can cause decreased platelet **aggregation** and are potent **vasodilators**

---

# Answer
With both iloprost and epoprostenol having comparable efficacy, epoprostenol is preferred due to less side effects, iloprost is preferred as it is inhaled